- ►annals.org L Chemello, L Cavalletto, C Casarin, P Bonetti, … - Annals of internal medicine, 1996 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To define long-term outcome in patients with chronic hepatitis C ... Cited by 93 - Related articles - BL Direct - All 3 versions
O Reichard, H Glaumann, A Frydén, G … - Hepatology, 1995 - interscience.wiley.com Fourteen patients with chronic hepatitis C who had a sustained response to a
60-week interferon alfa-2b treatment course were followed, biochemically and
virologically, 2 years after treatment cessation. Biopsies were repeated in ... Cited by 88 - Related articles - BL Direct - All 3 versions
JY Lau, M Mizokami, T Ohno, DA Diamond, J … - Lancet, 1993 - ncbi.nlm.nih.gov Serial serum samples and pretreatment and post-treatment liver tissue from
patients with chronic hepatitis C virus (HCV) infection were tested for HCV RNA
by reverse-transcription polymerase chain reaction and branched DNA signal ... Cited by 134 - Related articles - All 3 versions
S Vento, E Concia, T Ferraro - The New England Journal of Medicine, 1996 - nejm.highwire.org We followed for 92 to 99 months (mean, 93) 13 patients (9 men and 4 women; mean
age, 35 years; range, 21 to 54) who had received 3 million units of recombinant
interferon alfa-2a (Roferon rA, Roche) or interferon alfa-2b (Intron A, ... Cited by 20 - Related articles - All 4 versions
L Chemello, P Bonetti, L Cavalletto, F Talato, … - Hepatology, 1995 - interscience.wiley.com Alpha-interferon (IFN- ) is an effective treatment for chronic hepatitis C, but
only 20% to 30% of patients are apparently cured with the currently recommended
schedule of 3 MU given three times a week for 6 months. To evaluate the ... Cited by 179 - Related articles - BL Direct - All 3 versions
P Bonetti, L Chemello, C Antona, A Breda, P … - Journal of Viral Hepatitis, 1997 - ingentaconnect.com Several studies have recently attempted to define parameters that may be used to
predict the likelihood of obtaining a sustained response in an individual
patient [8–11]. This has been shown to correlate with pretreatment ... Cited by 7 - Related articles - BL Direct - All 2 versions
EK Manesis, C Papaioannou, A Gioustozi, G … - Hepatology, 1997 - interscience.wiley.com To compare two interferon (IFN) schedules for the treatment of chronic hepatitis
C, we followed 211 patients who received 3 million units IFN- 2b thrice weekly
for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 ... Cited by 34 - Related articles - BL Direct - All 3 versions
- ►annals.org M Shindo, K Arai, Y Sokawa, T Okuno - Annals of internal medicine, 1995 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To identify predictors of a long-term response to interferon- ... Cited by 78 - Related articles - All 3 versions
I Castillo, J Bartolomé, S Navas, S Gonzalez, … - Hepatology, 1994 - interscience.wiley.com We studied the long-term outcomes of 43 patients with chronic hepatitis C
treated with one or two interferon cycles, in relation to hepatitis C virus RNA
in serum and peripheral-blood mononuclear cells. After the first interferon ... Cited by 57 - Related articles - BL Direct - All 3 versions
A Larghi, A Tagger, A Crosignani, ML Ribero, … - Journal of medical virology, 1998 - interscience.wiley.com Whether sustained biochemical response and absence of serum HCV RNA in the 6-12
months following suspension of interferon- (IFN- ) therapy reflect definitive
viral clearance in patients with chronic hepatitis C virus (HCV) infection ... Cited by 29 - Related articles - BL Direct - All 3 versions
